BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28923896)

  • 1. Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen.
    Bobes RJ; Navarrete-Perea J; Ochoa-Leyva A; Anaya VH; Hernández M; Cervantes-Torres J; Estrada K; Sánchez-Lopez F; Soberón X; Rosas G; Nunes CM; García-Varela M; Sotelo-Mundo RR; López-Zavala AA; Gevorkian G; Acero G; Laclette JP; Fragoso G; Sciutto E
    Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28923896
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.
    Toledo A; Larralde C; Fragoso G; Gevorkian G; Manoutcharian K; Hernández M; Acero G; Rosas G; López-Casillas F; Garfias CK; Vázquez R; Terrazas I; Sciutto E
    Infect Immun; 1999 May; 67(5):2522-30. PubMed ID: 10225916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium.
    Wu L; Diao Z; Deng X; Gao J; Zhou Z; Liu Y; Wang Y
    J Nanosci Nanotechnol; 2005 Aug; 5(8):1204-10. PubMed ID: 16193978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic papaya: a useful platform for oral vaccines.
    Fragoso G; Hernández M; Cervantes-Torres J; Ramírez-Aquino R; Chapula H; Villalobos N; Segura-Velázquez R; Figueroa A; Flores I; Jiménez H; Adalid L; Rosas G; Galvez L; Pezzat E; Monreal-Escalante E; Rosales-Mendoza S; Vazquez LG; Sciutto E
    Planta; 2017 May; 245(5):1037-1048. PubMed ID: 28194565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.
    Toledo A; Fragoso G; Rosas G; Hernández M; Gevorkian G; López-Casillas F; Hernández B; Acero G; Huerta M; Larralde C; Sciutto E
    Infect Immun; 2001 Mar; 69(3):1766-73. PubMed ID: 11179354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis.
    Manoutcharian K; Díaz-Orea A; Gevorkian G; Fragoso G; Acero G; González E; De Aluja A; Villalobos N; Gómez-Conde E; Sciutto E
    Vet Immunol Immunopathol; 2004 May; 99(1-2):11-24. PubMed ID: 15113650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GK1 antibodies damage Taenia crassiceps cysticerci through complement activation.
    Núñez G; Villalobos N; Herrera CP; Navarrete-Perea J; Méndez A; Martinez-Maya JJ; Bobes RJ; Fragoso G; Sciutto E; Aguilar L; Del Arenal IP
    Parasitol Res; 2018 Aug; 117(8):2543-2553. PubMed ID: 29876861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli.
    Gauci C; Jayashi C; Lightowlers MW
    Bioengineered; 2013; 4(5):343-7. PubMed ID: 23196744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A.
    Kyngdon CT; Gauci CG; Gonzalez AE; Flisser A; Zoli A; Read AJ; Martínez-Ocaña J; Strugnell RA; Lightowlers MW
    Parasite Immunol; 2006 May; 28(5):191-9. PubMed ID: 16629704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the protective potential of a Taenia solium cysticercus mimotope on murine cysticercosis.
    Capelli-Peixoto J; Chávez-Olórtegui C; Chaves-Moreira D; Minozzo JC; Gabardo J; Teixeira KN; Thomaz-Soccol V; Alvarenga LM; de Moura J
    Vaccine; 2011 Nov; 29(51):9473-9. PubMed ID: 22027483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens.
    Gauci CG; Jayashi CM; Gonzalez AE; Lackenby J; Lightowlers MW
    Vaccine; 2012 Jun; 30(26):3824-8. PubMed ID: 22521850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel enolase from Taenia solium metacestodes and its evaluation as an immunodiagnostic antigen for porcine cysticercosis.
    Ponce R; León-Janampa N; Gilman RH; Liendo R; Roncal E; Luis S; Quiñones-Garcia S; Silverstein Z; García HH; Gonzales A; Sheen P; Zimic M; Pajuelo MJ;
    Exp Parasitol; 2018 Aug; 191():44-54. PubMed ID: 29885292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.
    Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
    J Parasitol; 2013 Aug; 99(4):686-92. PubMed ID: 23445359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide epitopes of the Taenia solium antigen Ts8B2 are immunodominant in human and porcine cysticercosis.
    Ferrer E; Martínez-Escribano JA; Barderas ME; González LM; Cortéz MM; Dávila I; Harrison LJ; Parkhouse RM; Gárate T
    Mol Biochem Parasitol; 2009 Dec; 168(2):168-71. PubMed ID: 19712705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis.
    Deckers N; Saerens D; Kanobana K; Conrath K; Victor B; Wernery U; Vercruysse J; Muyldermans S; Dorny P
    Int J Parasitol; 2009 Apr; 39(5):625-33. PubMed ID: 19041315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysticercosis: identification and cloning of protective recombinant antigens.
    Manoutcharian K; Rosas G; Hernandez M; Fragoso G; Aluja A; Villalobos N; Rodarte LF; Sciutto E
    J Parasitol; 1996 Apr; 82(2):250-4. PubMed ID: 8604092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to a recombinant attenuated Salmonella typhimurium strain expressing a Taenia solium oncosphere antigen TSOL18.
    Ding J; Zheng Y; Wang Y; Dou Y; Chen X; Zhu X; Wang S; Zhang S; Liu Z; Hou J; Zhai J; Yan H; Luo X; Cai X
    Comp Immunol Microbiol Infect Dis; 2013 Jan; 36(1):17-23. PubMed ID: 23219684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review.
    Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
    J Parasitol; 2013 Aug; 99(4):693-702. PubMed ID: 23409920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic epitope variability within Taenia solium 8 kDa antigen family: implications for cysticercosis immunodetection.
    Ferrer E; Sánchez J; Milano A; Alvarez S; La Rosa R; Lares M; González LM; Cortéz MM; Dávila I; Harrison LJ; Parkhouse RM; Gárate T
    Exp Parasitol; 2012 Jan; 130(1):78-85. PubMed ID: 22075212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.
    Flisser A; Gauci CG; Zoli A; Martinez-Ocaña J; Garza-Rodriguez A; Dominguez-Alpizar JL; Maravilla P; Rodriguez-Canul R; Avila G; Aguilar-Vega L; Kyngdon C; Geerts S; Lightowlers MW
    Infect Immun; 2004 Sep; 72(9):5292-7. PubMed ID: 15322025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.